Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.
作者信息
Mandell Lionel A, Wunderink Richard G, Anzueto Antonio, Bartlett John G, Campbell G Douglas, Dean Nathan C, Dowell Scott F, File Thomas M, Musher Daniel M, Niederman Michael S, Torres Antonio, Whitney Cynthia G
机构信息
McMaster University Medical School, Hamilton, Ontario, Canada.
出版信息
Clin Infect Dis. 2007 Mar 1;44 Suppl 2(Suppl 2):S27-72. doi: 10.1086/511159.
Abstract
摘要
相似文献
1
Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.
Clin Infect Dis. 2007 Mar 1;44 Suppl 2(Suppl 2):S27-72. doi: 10.1086/511159.
2
Hot Topics in Primary Care: Community-Acquired Bacterial Pneumonia: Is There Anything New?
J Fam Pract. 2017 Apr;66(4 Suppl):S10-S15.
3
Antibiotic therapy for community-acquired pneumonia.
Clin Chest Med. 1999 Sep;20(3):589-98, ix. doi: 10.1016/s0272-5231(05)70238-0.
4
Primary care summary of the British Thoracic Society Guidelines for the management of community acquired pneumonia in adults: 2009 update. Endorsed by the Royal College of General Practitioners and the Primary Care Respiratory Society UK.
Prim Care Respir J. 2010 Mar;19(1):21-7. doi: 10.4104/pcrj.2010.00014.
5
Clinical Guideline Highlights for the Hospitalist: 2019 American Thoracic Society/Infectious Diseases Society of America Update on Community-Acquired Pneumonia.
J Hosp Med. 2020 Dec;15(12):743-745. doi: 10.12788/jhm.3444.
6
Diagnosis and management of community-acquired pneumonia in adults.
Am Fam Physician. 2011 Jun 1;83(11):1299-306.
7
Validation of the Infectious Diseases Society of America/American Thoracic Society criteria to predict severe community-acquired pneumonia caused by Streptococcus pneumoniae.
Am J Emerg Med. 2009 Oct;27(8):968-74. doi: 10.1016/j.ajem.2008.07.037.
8
[The Japanese Respiratory Society guidelines for management of community-acquired pneumonia in adults].
Nihon Rinsho. 2003 Feb;61 Suppl 2:677-81.
9
Treating community-acquired pneumonia.
Nurse Pract. 2004 Jun;29(6):11-3. doi: 10.1097/00006205-200406000-00003.
10
BTS guidelines for the management of community acquired pneumonia in adults: update 2009.
Thorax. 2009 Oct;64 Suppl 3:iii1-55. doi: 10.1136/thx.2009.121434.
引用本文的文献
1
Is Shorter Better in Oncology Patients, Too? A Retrospective Cohort Study of Short- Versus Long-Course Antibiotic Therapy for Uncomplicated Infections in Solid Tumor Patients Receiving Care in Ambulatory Oncology Clinics.
Open Forum Infect Dis. 2025 Aug 21;12(9):ofaf505. doi: 10.1093/ofid/ofaf505. eCollection 2025 Sep.
2
Metabolic Dysfunction-Associated Steatotic Liver Disease Shapes a Distinct Semaphorin-Cytokine Immune Signature in Severe Community-Acquired Pneumonia.
Int J Mol Sci. 2025 Aug 21;26(16):8095. doi: 10.3390/ijms26168095.
3
Guideline-Concordant Antibiotic Treatment for Hospitalised Patients with Community-Acquired Pneumonia and Clinical Outcomes at a Tertiary Hospital in Australia.
Antibiotics (Basel). 2025 Aug 20;14(8):845. doi: 10.3390/antibiotics14080845.
4
Pneumococcal Pyopericardium With Xiphoid Osteomyelitis in HIV/AIDS: A Rare but Potentially Fatal Complication.
Case Rep Cardiol. 2025 Aug 13;2025:5008190. doi: 10.1155/cric/5008190. eCollection 2025.
5
Clinical characteristics of Chlamydia psittaci pneumonia: a single-center, retrospective study over 5 years.
BMC Infect Dis. 2025 Aug 16;25(1):1027. doi: 10.1186/s12879-025-11450-z.
6
Development of a pilot machine learning model to predict successful cure in critically ill patients with community-acquired pneumonia.
medRxiv. 2025 Jul 16:2025.07.14.25331407. doi: 10.1101/2025.07.14.25331407.
7
Risk prediction models for mortality in patients with severe pneumonia: a systematic review and meta-analysis.
Front Med (Lausanne). 2025 Jul 23;12:1564545. doi: 10.3389/fmed.2025.1564545. eCollection 2025.
8
Evaluation of the Efficacy of a Nomogram to Predict Multidrug-Resistant Pulmonary Infections Based on Data from Neurosurgery Ward Patients.
Infect Drug Resist. 2025 Jul 26;18:3723-3734. doi: 10.2147/IDR.S527114. eCollection 2025.
9
Effects of Antibiotic De-Escalation on Outcomes in Severe Community-Acquired Pneumonia: An Inverse Propensity Score-Weighted Analysis.
Antibiotics (Basel). 2025 Jul 17;14(7):716. doi: 10.3390/antibiotics14070716.
10
The Burden of Hospitalization and Rehospitalization Among Patients Hospitalized with Severe Community-Acquired Bacterial Pneumonia in the United States, 2018-2022.
Antibiotics (Basel). 2025 Jun 25;14(7):642. doi: 10.3390/antibiotics14070642.
本文引用的文献
1
Coccidioidomycosis as a common cause of community-acquired pneumonia.
Emerg Infect Dis. 2006 Jun;12(6):958-62. doi: 10.3201/eid1206.060028.
2
Brief communication: severe hepatotoxicity of telithromycin: three case reports and literature review.
Ann Intern Med. 2006 Mar 21;144(6):415-20. doi: 10.7326/0003-4819-144-6-200503210-00121. Epub 2006 Feb 15.
3
Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States.
JAMA. 2006 Feb 22;295(8):891-4. doi: 10.1001/jama.295.8.joc60020. Epub 2006 Feb 2.
4
Antivirals for influenza in healthy adults: systematic review.
Lancet. 2006 Jan 28;367(9507):303-13. doi: 10.1016/S0140-6736(06)67970-1.
5
High levels of adamantane resistance among influenza A (H3N2) viruses and interim guidelines for use of antiviral agents--United States, 2005-06 influenza season.
MMWR Morb Mortal Wkly Rep. 2006 Jan 20;55(2):44-6.
6
Validation of a predictive rule for the management of community-acquired pneumonia.
Eur Respir J. 2006 Jan;27(1):151-7. doi: 10.1183/09031936.06.00062505.
7
Oseltamivir resistance during treatment of influenza A (H5N1) infection.
N Engl J Med. 2005 Dec 22;353(25):2667-72. doi: 10.1056/NEJMoa054512.
8
Effect of increasing the intensity of implementing pneumonia guidelines: a randomized, controlled trial.
Ann Intern Med. 2005 Dec 20;143(12):881-94. doi: 10.7326/0003-4819-143-12-200512200-00006.
9
Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine.
JAMA. 2005 Oct 26;294(16):2043-51. doi: 10.1001/jama.294.16.2043.
10
American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: controlling tuberculosis in the United States.
Am J Respir Crit Care Med. 2005 Nov 1;172(9):1169-227. doi: 10.1164/rccm.2508001.
Zotero 插件